Literature DB >> 12107732

Urinary excretion of 8-oxo-7, 8-dihydro-2'-deoxyguanosine as a predictor of the development of diabetic nephropathy.

Y Hinokio1, S Suzuki, M Hirai, C Suzuki, M Suzuki, T Toyota.   

Abstract

AIMS/HYPOTHESIS: The increased oxidative stress in diabetes is known to contribute to the progression of diabetes and its complications. We have reported a significant relation between the content of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), a product of oxidative DNA damage in urine or leukocytes and the severity of diabetic nephropathy and retinopathy [1]. We investigated whether 8-oxodG in urine or leukocytes is associated with the progression of diabetic nephropathy.
METHODS: We measured urinary 8-oxodG contents at entry and carried out a prospective longitudinal study to assess the progression of nephropathy over 5 years.
RESULTS: There was a significant progression of diabetic nephropathy in the patients with higher excretion of 8-oxodG in urine compared with the patients with moderate or lower excretion of 8-oxodG. There was no significant association between the leukocyte 8-oxodG contents and the development of nephropathy. The multivariate logistic regression analysis suggests that the urinary 8-oxodG was the strongest predictor of nephropathy among several known risk factors. CONCLUSION/
INTERPRETATION: This study provides evidence that increased oxidative stress has a primary role in the pathogenesis of diabetic nephropathy. A local enhancement of oxidative stress in diabetic kidney might explain the possible linkage between the increased urinary excretion of 8-oxodG and the development of nephropathy. 8-oxodG in urine is a useful clinical marker to predict the development of diabetic nephropathy in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107732     DOI: 10.1007/s00125-002-0831-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

Review 1.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.

Authors:  M J Sampson; D A Hughes
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

Review 2.  Aldosterone and CKD in metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 3.  Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.

Authors:  So-Young Lee; Mary E Choi
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

4.  Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Authors:  Manuel Sanchez; Ronan Roussel; Samy Hadjadj; Abdul Moutairou; Michel Marre; Gilberto Velho; Kamel Mohammedi
Journal:  Diabetologia       Date:  2017-11-28       Impact factor: 10.122

Review 5.  Early detection of diabetic kidney disease: Present limitations and future perspectives.

Authors:  Chih-Hung Lin; Yi-Cheng Chang; Lee-Ming Chuang
Journal:  World J Diabetes       Date:  2016-07-25

6.  Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage.

Authors:  Samy L Habib; Anamika Yadav; Dawit Kidane; Robert H Weiss; Sitai Liang
Journal:  Cell Cycle       Date:  2016-09-09       Impact factor: 4.534

Review 7.  Aldosterone in salt-sensitive hypertension and metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

Review 8.  Diabetic nephropathy and antioxidants.

Authors:  Majid Tavafi
Journal:  J Nephropathol       Date:  2013-01-01

Review 9.  Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 10.  Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Authors:  Runa Lindblom; Gavin Higgins; Melinda Coughlan; Judy B de Haan
Journal:  Rev Diabet Stud       Date:  2015-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.